Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis

Fig. 2

Liver findings and serum ALT levels in the control, MSG, and MSG + FOS mice at 18 weeks. a Histological findings (hematoxylin/eosin staining, 100× magnification, scale bar = 100 μm), b Mean NAFLD activity score, c Mean serum ALT levels. **p < 0.01. ALT, alanine aminotransferase; FOS, fructo-oligosaccharides; MSG, monosodium glutamate; NAFLD, non-alcoholic fatty liver disease

Back to article page